Photo: Depositphotos
Sep 20, 2025, 13:58
Novo Nordisk Haemophilia Foundation Partners Drive Global Progress in Low-Dose Prophylaxis and Carrier Awareness
Novo Nordisk Haemophilia Foundation has shared a post on LinkedIn:
“NNHF Partners Highlight Meeting
We had an incredible session with strong engagement from 75 participants, featuring three powerful keynotes and fantastic engagement from our global partners. Your contributions made this virtual meeting truly impactful!
Key notes from our partners:
- South Africa – Dr Yasmin Goga and Molly Ndebele spoke about advocating for low-dose prophylaxis (vs. on-demand treatment) in low-resource settings, and highlighted the critical role of nurses in making this approach possible.
- Latin America – Yuri Arango highlighted important work with Carrier Women with Bleeding Disorders, driving awareness and better care pathways.
These discussions show what’s possible when we learn from each other and work together.
Are you a partner and want to join our next session? Stay tuned for the next invitation coming in February 2026!”
Stay informed with Hemostasis Today.
-
Jan 11, 2026, 11:00Benjamin YQ Tan on Impacts of Early Cognitive and Psychological Statuses Post-Stroke
-
Jan 11, 2026, 10:46Salvador Payán Pernía: Leukodepletion Reduces Microplastic Burden in Red Blood Cell Concentrates
-
Jan 11, 2026, 10:36Mariasanta Napolitano on Pregnancy and Delivery Outcomes in Women with Hemophilia
-
Jan 11, 2026, 10:19Quick Explanation of Types of Blood Transfusion from John Amako
-
Jan 11, 2026, 06:18Filippo Cademartiri on Why Vascular Health Is Cognitive Health
-
Jan 11, 2026, 06:01Maira Dastgir N on Cannabis-Induced Ischemic Stroke
-
Jan 11, 2026, 05:51Nishant K Mishra on Preventing Post-Stroke Seizures
-
Jan 11, 2026, 05:41Indunil Karunarathna on CSF Xanthochromia in SAH
-
Jan 11, 2026, 05:22Mitchell Elkind on The New York Times Brain Health Challenge: Food Is Brain Medicine!